Kawaldip Sehmi

Born and brought up in Kenya, Kawaldip has been championing patients’ right to access personalised health care, biotherapeutics, cell and gene therapies through robust legal, policy, practice & institutional frameworks in healthcare.

Currently as the CEO of the International Alliance of Patients Organization and convener of the African Medicines Agency Treaty Alliance (AMATA), he is keen on a well-regulated African medicines and health devices market and research and development ecosystem from Cape to Cairo, and from Mauritius to Cape Verde.

After collaborating with the International Prevention Research Institute (iPRI) on their landmark report The State of Oncology in Africa, Kawaldip is keen on improving cancer survivorship through early access to genomic based diagnostics and medicines, advocating access to immunotherapies and liquid biopsies and detection, imaging, and analysis of circulating tumour cells.

Kawaldip has an academic background in Public Health and Law and has a passionate belief in improving access to healthcare services and justice through digital healthcare (e-Health) and virtual courts (e-Law). As the CEO of an international mental health charity specialising in niche mental health services, he has experience of developing services supporting young people and adults with complex mental health, personality disorder and substance misuse problems through telehealth and digital mental health services.

A passionate advocate of WHO’s human rights-based approaches to health and of strengthening of the institutional, legislative, policy, practice and standards framework needed to support the achievement of health in all goals of the Sustainable Developmental Goals 2030 and universal health coverage SDG 3.8.